Scientists used genetic sequencing to discover that the vaccine used in the RV144 HIV vaccine trial, involving 16,000 men and women in Thailand, did offer some protection against certain HIV viruses. The results were published Sept. 10 in the online edition of Nature.
The U.S. Food and Drug Administration decided today, July 16, to approve the use of an HIV treatment drug for reducing the risk of acquiring HIV.
By Keegan Hamilton
Now, as HIV/AIDS researchers worldwide seem to be moving closer to a possible HIV vaccine, Hu has received a vote of confidence from the Bill & Melinda Gates Foundation for his contributions to the field.
By Pam Belluck; posted 10/03/2011; 5:05 pm.
From PC Magazine; Leslie Horn; 9/19/2011; 10:42am EST
Revalesio, a pioneering biotechnology company based in Tacoma, recently signed an 18-month contract with the Katze lab at the UW to bring hope to sufferers of influenza, HIV and hepatitis C.
June 10, 2011 (New York) – The Global Forum on MSM & HIV (MSMGF) welcomes the progress represented in the new 2011 United Nations Political Declaration on HIV and AIDS, expected to be formally
Had the last word: "It's because of who's affected. Cholera is ignored because it's a disease of the poorest of the poor."